Skip to main content
Richard Sterling, MD, Gastroenterology, Richmond, VA, VCU Medical Center

RichardK.SterlingMD

Gastroenterology • Richmond, VA

Hepatology & Liver Transplantation

Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine

Join to view full profile

Dr. Sterling is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sterling's full profile

Already have an account?

Education & Training

  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1988 - 1991
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1988

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 1989 - 2024
  • OH State Medical License
    OH State Medical License 1994 - 2002
  • American Board of Internal Medicine Gastroenterology
  • American Board of Internal Medicine Transplant Hepatology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-Infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study  
    Mandana Khalili, Mark Sulkowski, Marc G Ghany, Richard K Sterling, Raymond T Chung, David E Kleiner, Mamta K Jain, Nature
  • A Comprehensive Assessment of Patient Reported Symptom Burden, Medical Comorbidities, and Functional Well Being in Patients Initiating Direct Acting Antiviral Therapy ...  
    Souvik Sarkar, Michael W. Fried, Richard K. Sterling, Paul W. Stewart, Nancy Reau, Joseph K. Lim, David R. Nelson, Marina Serper, PLoS One
  • Proton Pump Inhibitor Initiation and Withdrawal Affects Gut Microbiota and Readmission Risk in Cirrhosis  
    Michael Fuchs, Puneet Puri, Mohammad S Siddiqui, Douglas M Heuman, Jasmohan S Bajaj, Arun J Sanyal, Velimir Luketic, Richard K Sterling, Nature

Press Mentions

  • VCTE Superior Marker for Measuring Fibrosis in Patients with HBV/HIV
    VCTE Superior Marker for Measuring Fibrosis in Patients with HBV/HIVJuly 10th, 2019
  • Improved Definition of HBV Phenotypes Based on Genotype-Specific Levels of Hepatitis B S Antigen
    Improved Definition of HBV Phenotypes Based on Genotype-Specific Levels of Hepatitis B S AntigenDecember 27th, 2018
  • VCU Medical Exploring Groundbreaking Kidney Transplant Research
    VCU Medical Exploring Groundbreaking Kidney Transplant ResearchFebruary 22nd, 2018

Grant Support

  • Hepatitis B Clinical Research NetworkNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • The Relationship Of Hepatic Steatosis To Endothelial Dysfunction In PatientsNational Center For Research Resources2010
  • Spectrum Of Liver Disease In Patients Living With HIVNational Center For Research Resources2010
  • Relationship Of Metabolic Abnormalities To Hepatic Steatosis In HumanNational Center For Research Resources2010
  • Clinical Trial: HEP C Antiviral Long-Term Treatment Against Cirrhosis (Halt-C)National Center For Research Resources2010
  • Antiretroviral Therapy And The Hepatitis C Virus: A Limited Center TrialNational Center For Research Resources2010
  • A Pilot Study Of Therapy With Pioglitazone Prior To HCV Treatment In HIV-1 AnNational Center For Research Resources2010
  • HCV-HIV Coinfection: Impact Of Immune DysfunctionNational Center For Research Resources2005–2010
  • Relationship Of Metabolic Abnormalities To Hepatic Steatosis In Human ImmunodNational Center For Research Resources2008–2009
  • Relationship Of Metabolic Abnormalities To Hepatic Steatosis In HIVNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
  • Peginterferon Alpha-2a PLUS Ribavirin In Chronic Hepatitis C And HIVNational Center For Research Resources2005–2007
  • HCV-HIV Coinfection: Impact Of Immune DysfunctionNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2007
  • The Immunologic Effects Of (Hcv)In Patients With HIV CoinfectionNational Center For Research Resources2005–2006
  • Peg_interferon A-2b + Ribivirin For Treatment Of HCV In HIV Infected PersonsNational Center For Research Resources2005–2006
  • The Spectrum And Immunologic Effects Of HCV In Patients With HIVNational Center For Research Resources2005
  • Peg-Interferon A-2b + Ribavirin For Treatment Of HCVNational Center For Research Resources2004
  • Mycophenolate Mofetil In Primary Sclerosing CholangitisNational Center For Research Resources2004
  • Immunologic Effects Of HCV In Patients With HIV CoinfectNational Center For Research Resources2004
  • Immunologic Effects Of HCV In Patients With HIVNational Center For Research Resources2004
  • Glucose Metabolism In Hepatitis C--Glucose IntoleranceNational Center For Research Resources2000

Hospital Affiliations

Dr. Richard Sterling, Dr. Richard Sterling, MD, Dr. R Sterling, Dr. Richard K. Sterling